JPRN-UMIN000023825招募中未知
An exploratory study on the efficacy and safety of Hangesyasinto (TJ-14) for DCF chemotherapy or DCF-RT chemoradiotherapy induced diarrhea in the patients with advanced esophageal cancer. - Effect of Hangesyasinto for DCF chemotherapy or DCF-RT chemoradiotherapy induced diarrhea in patients with advanced esophageal cancer.
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. aldosteronism 2. myopathy or hypokalemia 3. while taking the Kampo medicines 4. less than 4 weeks after previous chemo or radio completion 5. medical history of serious drug allergy 6. presence of serious complications (heart, lung, liver, or kidney disease or psychological disorders or bleeding) 7. HBV, HCV infection 8. pregnant or breast-feeding females and females who have a possibility of pregnancy 9. patients who are thought inadequate by their doctor
研究者
相似试验
招募中
不适用
A exploratory study of the efficacy and safety of oxaliplatin in combination with S-1 in the treatment of non-resectable gastric cancernon-resectable gastric cancer or reccurent gastric cancerJPRN-UMIN000002463niversity of Tokyo Hospital20
已完成
不适用
An exploratory study of the efficacy and safety of yokukansan for postoperative delirium in patients who underwent surgical resection of malignant tumor of digestive system.Digestive system cancerJPRN-UMIN000013235Hitachi,Ltd.,Hitachi General Hospital40
尚未招募
Unknown
Study on the safety and efficacy of upper extremity motor function recovery after neuromodulatory stimulation using low-intensity focused ultrasound (NS-US200) in patients with ischemic strokeDiseases of the circulatory systemKCT0008320Korea University Anam Hospital12
招募中
2 期
An exploratory study of the safety and efficacy of disulfiram in progressive fibrosing interstitial lung diseaseinterstitial lung diseaseprogressive fibrosing interstitial lung diseaseD017563JPRN-jRCTs031220648rushiyama Hirokazu10
进行中（未招募）
不适用
An Exploratory Study of the Safety and Efficacy of Prophylactic Immunomodulatory Treatment in Myozyme-naive Cross-Reacting Immunologic Material (CRIM[-]) Patients With Infantile-Onset Pompe DiseasePompe disease (acid alpha-glucosidase deficiency)MedDRA version: 17.1Level: LLTClassification code 10036143Term: Pompe's diseaseSystem Organ Class: 100000004850EUCTR2015-000584-14-Outside-EU/EEAGenzyme Corporation Inc4